Computational multiscale toxicodynamic modeling of silver and carbon nanoparticle effects on mouse lung function

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Mukherjee, Dwaipayan ^a,b   Botelho, Danielle ^c   Gow, Andrew J ^c   Zhang, Junfeng ^d   Georgopoulos, Panos G ^a,b  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b The State University of New Jersey   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON NANOPARTICLE; LUNG SURFACTANT; NANOPARTICLE; PHOSPHOLIPID; SILVER NANOPARTICLE; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPUTER PREDICTION; CONTROLLED STUDY; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; LUNG FLUID; LUNG TOXICITY; MATHEMATICAL MODEL; MOUSE; NANOTOXICOLOGY; NONHUMAN; PARTICLE SIZE; SURFACE PROPERTY; TOXICOKINETICS; ZETA POTENTIAL;

ANIMALS; COMPUTER SIMULATION; LUNG; METAL NANOPARTICLES; MICE; MODELS, BIOLOGICAL; NANOTUBES, CARBON; PARTICLE SIZE; RESPIRATORY FUNCTION TESTS; XENOBIOTICS;

EID: 84891802195     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080917     Document Type: Article

References (58)

1. Wijnhoven S, Peijnenburg W, Herberts C, Hagens W, Oomen A, et al. (2009) Nano-silver - a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 3: 109-138.
2. Love SA, Maurer-Jones MA, Thompson JW, Lin YS, Haynes CL (2012) Assessing Nanoparticle Toxicity. Annual Review of Analytical Chemistry 5: 181-205.
3. Notter RH (2000) Lung Surfactants: Basic Science and Clinical Applications, volume 149 of Lung Biology in Health and Disease. New York: Marcel Dekker.
4. Goerke J (1998) Pulmonary surfactant: functions and molecular composition. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1408: 79-89.
5. Rooney SA, Young SL, Mendelson CR (1994) Molecular and cellular processing of lung surfactant. FASEB J 8: 957-67.
6. Archie J (1973) A mathematical model for pulmonary mechanics: The alveolar surface contribution. International Journal of Engineering Science 11: 659-671.
7. Martini WZ, Chinkes DL, Barrow RE, Murphey ED, Wolfe RR (1999) Lung surfactant kinetics in conscious pigs. American Journal of Physiology - Endocrinology And Metabolism 277: E187-E195.
8. Andreeva AV, Kutuzov MA, Voyno-Yasenetskaya TA (2007) Regulation of surfactant secretion in alveolar type II cells. American Journal of Physiology - Lung Cellular and Molecular Physiology 293: L259-L271.
9. Froh D, Gonzales LW, Ballard PL (1993) Secretion of Surfactant Protein A and Phosphatidylcholine from Type II Cells of Human Fetal Lung. American Journal of Respiratory Cell and Molecular Biology 8: 556-561.
10. Fisher AB, Dodia C, Ruckert P, Tao JQ, Bates SR (2010) Pathway to lamellar bodies for surfactant protein A. American Journal of Physiology - Lung Cellular and Molecular Physiology 299: L51-L58.
11. Robertson B, Van Golde LMG, Batenburg JJ, editors (1992) Pulmonary Surfactant: From Molecular Biology to Clinical Practice. Amsterdam: Elsevier Science Publishers.
12. Wright JR, Dobbs LG (1991) Regulation of Pulmonary Surfactant Secretion and Clearance. Annual Review of Physiology 53: 395-414.
13. Gurel O, Ikegami M, Chroneos ZC, Jobe AH (2001) Macrophage and type II cell catabolism of SP-A and saturated phosphatidylcholine in mouse lungs. American Journal of Physiology - Lung Cellular and Molecular Physiology 280: L1266-L1272.
14. Pettenazzo A, Jobe A, Humme J, Seidner S, Ikegami M (1988) Clearance of surfactant phosphatidylcholine via the upper airways in rabbits. J Appl Physiol 65: 2151-5.
15. Walters RW, Jenq RR, Hall SB (2000) Distinct Steps in the Adsorption of Pulmonary Surfactant to an Air-Liquid Interface. Biophysical Journal 78: 257-266.
16. Archie JP (1968) An Analytic Evaluation of a Mathematical Model for the Effect of Pulmonary Surfactant on Respiratory Mechanics. Diseases of the Chest 53: 759-764.
17. Suzuki Y, Fujita Y, Kogishi K (1989) Reconstitution of tubular myelin from synthetic lipids and proteins associated with pig pulmonary surfactant. American Review of Respiratory Diseases 140: 75-81.
18. Hawgood S, Shiffer K (1991) Structure and properties of the surfactant-associated proteins. Annual Review of Physiology 53: 375-394.
19. Bourbon J, editor (1991) Pulmonary surfacxtant: biochemical, functional, regulatory, and clinical concepts. Florida: CRC Press.
20. Bakshi MS, Zhao L, Smith R, Possmayer F, Petersen NO (2008) Metal nanoparticle pollutants interfere with pulmonary surfactant function in vitro. Biophys J 94: 855-68.
21. Schleh C, Hohlfeld JM (2009) Interaction of nanoparticles with the pulmonary surfactant system. Inhal Toxicol 21 Suppl 1: 97-103.
22. Kendall M, Brown L, Trought K (2004) Molecular Adsorption at Particle Surfaces: A PM Toxicity Mediation Mechanism. Inhalation Toxicology 16: 99-105.
23. Shelley SA, L'Heureux MV, Balis JU (1975) Characterization of lung surfactant: factors promoting formation of artifactual lipid-protein complexes. J Lipid Res 16: 224-34.
24. Lai Y, Chiang P, Blom J, Li N, Others (2008) Comparison of In vitro Nanoparticles Uptake in Various Cell Lines and In vivo Pulmonary Cellular Transport in Intratracheally Dosed Rat Model. Nanoscale Research Letters 3: 321-329.
25. Su D, Ma R, Salloum M, Zhu L (2010) Multi-scale study of nanoparticle transport and deposition in tissues during an injection process. Medical & Biological Engineering & Computing 48: 853-863.
26. Oberdorster G, Oberdorster E, Oberdorster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113: 823-39.
27. Tabata Y, Ikada Y (1988) Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage. Biomaterials 9: 356-362.
28. Harush-Frenkel O, Debotton N, Benita S, Altschuler Y (2007) Targeting of nanoparticles to the clathrin-mediated endocytic pathway. Biochem Biophys Res Commun 353: 26-32.
29. Simionescu D, Simionescu M (1983) Differentiated distribution of the cell surface charge on the alveolar-capillary unit. Characteristic paucity of anionic sites on the air-blood barrier. Microvasc Res 25: 85-100.
30. Kemp S, Thorley A, Gorelik J, Seckl M, Others (2008) Immortalization of Human Alveolar Epithelial Cells to Investigate Nanoparticle Uptake. American Journal of Respiratory Cell and Molecular Biology 39: 591-597.
31. Ruge CA, Kirch J, Caadas O, Schneider M, Perez-Gil J, et al. (2011) Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A. Nanomedicine: Nanotechnology, Biology and Medicine 7: 690-693.
32. Chithrani BD, Ghazani AA, Chan WCW (2006) Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells. Nano Letters 6: 662-668.
33. Beduneau A, Ma Z, Grotepas C, Kabanov A, Rabinow B (2009) Facilitated Monocyte-Macrophage Uptake and Tissue Distribution of Superparamagnetic Iron-Oxide Nanoparticles. PLoS ONE 4: e4343.
34. Takenaka S, Karg E, Roth C, Schulz H, Others (2001) Pulmonary and Systemic Distribution of Inhaled Ultrafine Silver Particles in Rats. Environmental Health Perspectives 109(suppl. 4).
35. Raabe OG, Al-Bayati MA, Teague SV, Rasolt A (1988) Regional Deposition of Inhaled Monodisperse Coarse and Fine Aerosol Particles in Small Laboratory Animals. Annals of Occupational Hygiene 32: 53-63.
36. Otis AB, McKerrow CB, Bartlett RA, Mead J, McIlroy MB, et al. (1956) Mechanical Factors in Distribution of Pulmonary Ventilation. Journal of Applied Physiology 8: 427-443.
37. Hildebrandt J (1970) Pressure-volume data of cat lung interpreted by a plastoelastic, linear viscoelastic model. Journal of Applied Physiology 28: 365-372.
38. Hantos Z, Daroczy B, Suki B, Nagy S, Fredberg JJ (1992) Input impedance and peripheral inhomogeneity of dog lungs. Journal of Applied Physiology 72: 168-178.
39. Thamrin C, Janosi T, Collins R, Sly P, Hantos Z (2004) Sensitivity analysis of Respiratory Parameter Estimates in the Constant-Phase Model. Annals of Biomedical Engineering 32: 815-822.
40. Nel A, Xia T, Madler L, Li N (2006) Toxic potential of materials at the nanolevel. Science 311: 622-7.
41. Jang J, Lim DH, Choi IH (2010) The impact of nanomaterials in immune system. Immune Netw 10: 85-91.
42. Johansson J, Curstedt T, Robertson B (1994) The proteins of the surfactant system. Eur Respir J 7: 372-391.
43. Wu L, Zhang G, Luo Q, Liu Q (2008) An image-based rat model for Monte Carlo organ dose calculations. Medical Physics 35: 3759-3764.
44. Moessinger AC, Harding R, Adamson TM, Singh M, Kiu GT (1990) Role of lung uid volume in growth and maturation of the fetal sheep lung. J Clin Invest 86: 1270-7.
45. Knust J, Ochs M, Gundersen HJ, Nyengaard JR (2009) Stereological estimates of alveolar number and size and capillary length and surface area in mice lungs. Anat Rec (Hoboken) 292: 113-22.
46. Bastacky J, Lee CY, Goerke J, Koushafar H, Yager D, et al. (1995) Alveolar lining layer is thin and continuous: low-temperature scanning electron microscopy of rat lung. J Appl Physiol 79: 1615-28.
47. Rudiger M, Wendt S, Kothe L, Burkhardt W, Wauer RR, et al. (2007) Alterations of alveolar type II cells and intraalveolar surfactant after bronchoalveolar lavage and peruorocarbon ventilation. 48. An electron microscopical and stereological study in the rat lung. Respiratory Research 8: 1-9.
48. Kubota Y, Iwasaki Y, Harada H, Yokomura I, Ueda M, et al. (1999) Depletion of alveolar macrophages by treatment with 2-chloroadenosine aerosol. Clin Diagn Lab Immunol 6: 452-6.
49. Young SL, Kremers SA, Apple JS, Crapo JD, Brumley GW (1981) Rat lung surfactant kinetics biochemical and morphometric correlation. Journal of Applied Physiology 51: 248-253.
50. Hawgood S, Benson BJ, Hamilton RL (1985) Effects of a Surfactant-Associated Protein and Calcium ions on the Structure and Surface Activity of Lung Surfactant Lipids. Biochemistry 24: 184-190.
51. Bates SR, Tao JQ, Notarfrancesco K, DeBolt K, Shuman H, et al. (2003) Effect of surfactant protein A on granular pneumocyte surfactant secretion in vitro. American Journal of Physiology Lung Cell Molecular Physiology 285: L1055- L1065.
52. Muller B, Garn H, Hochscheid R (2003) Impaired recycling of surfactant-like liposomes in type II pneumocytes from injured lungs. Thorax 58: 127-134.
53. Meyer KC, Sharma A, Brown R, Weatherly M, Moya FR, et al. (2000) Function and Composition of Pulmonary Surfactant and Surfactant-Derived Fatty Acid Profiles Are Altered in Young Adults With Cystic Fibrosis*. Chest 118: 164-174.
54. Oosterlaken-Dijksterhuis M, Van Eijk M, Van Buel B, Van Golde LMG, Haagsman HP (1991) Surfactant protein composition of lamellar bodies isolated from rat lung. Biochemical Journal 274: 115-119.
55. Possmayer F, Nag K, Rodriguez K, Qanbar R, Schurch S (2001) Surface activity in vitro: role of surfactant proteins. Comp Biochem Physiol A Mol Integr Physiol 129: 209-20.
56. Clegg GR, Tyrrell C, McKechnie SR, Beers MF, Harrison D, et al. (2005) Coexpression of RTI40 with alveolar epithelial type II cell proteins in lungs following injury: identification of alveolar intermediate cell types. American Journal of Physiology - Lung Cellular and Molecular Physiology 289: L382-L390.
57. Chen J, Chen Z, Narasaraju T, Jin N, Liu L (2004) Isolation of highly pure alveolar epithelial type I and type II cells from rat lungs. Laboratory Investigation 84: 727-735.
58. Morgan A, Talbot RJ (1992) Effects of inhaled alpha-emitting actinides on mouse alveolar macrophages. Environ Health Perspect 97: 177-84.